We are live on ! Find out more
PAIA

Park Avenue Institutional Advisers Portfolio holdings

AUM $199M
1-Year Est. Return 36.92%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+36.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
-$514K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
+$497K
2
+$210K
3
+$175K

Sector Composition

Rank Sector Weight
1 Healthcare 0%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JA
1
Janus Henderson AA-A CLO ETF
JA
$148M
$100M 50.38%
2,000,000
JABS
2
Janus Henderson Asset-Backed Securities ETF
JABS
$135M
$98.6M 49.62%
1,975,000
BRZE icon
3
Braze
BRZE
$2.99B
– –
-8,890
RVMD icon
4
Revolution Medicines
RVMD
$44B
– –
-5,115
TTAN
5
ServiceTitan Inc
TTAN
$8.19B
– –
-2,757

Similar funds

PS
Pennant Select Summit, New Jersey $199M AUM 147.97% 1-Year Est. Return
PMIA
Patrick Mauro Investment Advisor Oak Brook, Illinois $199M AUM 9.61% 1-Year Est. Return
PFA
Plotkin Financial Advisors Chevy Chase, Maryland $199M AUM 19.26% 1-Year Est. Return
KL
KilterHowling LLC Boulder, Colorado $198M AUM 12.9% 1-Year Est. Return
SPI
Strategic Planning Inc Columbus, Ohio $199M AUM 20.31% 1-Year Est. Return
BMA
Brooks Moore & Associates Chattanooga, Tennessee $199M AUM 21.09% 1-Year Est. Return
CWM
Comprehensive Wealth Management Lynnwood, Washington $198M AUM 11.59% 1-Year Est. Return
FU
Fairfield University Fairfield, Connecticut $200M AUM 15.03% 1-Year Est. Return

Park Avenue Institutional Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Park Avenue Institutional Advisers held 5 positions worth $199M, down 0.26% from $199M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Park Avenue Institutional Advisers's Q2 2026 filing shows 3 closed positions. The largest sale was Revolution Medicines, an estimated $497K.

By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.25% a quarter earlier, followed by Technology.

  • Park Avenue Institutional Advisers fully exited Revolution Medicines in Q2 2026, selling an estimated $497K.
  • Park Avenue Institutional Advisers's ten largest holdings make up 100% of its $199M portfolio in Q2 2026.
  • Park Avenue Institutional Advisers opened 0 new positions and closed 3 in Q2 2026.
  • Park Avenue Institutional Advisers's portfolio value fell 0.26% quarter-over-quarter to $199M.

Based on Park Avenue Institutional Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.